Gri Bio Inc. (GRI) Live Share Price, Invest From India

Gri Bio Inc. Stock Performance

as on March 28, 2026 at 6:58 am IST

Day's Low
Day's High
$2.22
Day's Price Range
$2.37
$2.25
1.33%
Downside
5.33%
Upside
52 Week's Low
52 Week's High
$2.10
52-Week Price Range
$311.36
$2.25
6.67%
Downside
13738.22%
Upside

Gri Bio Inc. share price movements today

Previous Close: $2.30
Open: $2.32
Volume: 489.4K
Day's Low - High: $2.22 - $2.37
52 Week Low - High: $2.10 - $311.36

Gri Bio Inc. Historical Returns

1 Month Return: -10.59 %
3 Month Return: -70.5 %
1 Year Return: -98.14 %
3 Year Return: 0 %
5 Year Return: 0 %

Gri Bio Inc. Stock Fundamentals & Key Indicators

Check Gri Bio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.3M

EPS (TTM)

-15.37

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-12.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-238.17%

Gri Bio Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gri Bio Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Gri Bio Inc.	BUY	$3.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.5B	132.92%	140.84	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.2B	101.77%	29.58	32.94%
Beone Medicines Ltd	NA	$31.8B	NA	112.58	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.0B	54.69%	18.25	31.41%

Stock Returns calculator for Gri Bio Inc. Stock including INR - Dollar returns

The Gri Bio Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Gri Bio Inc. investment value today

Current value as on today

₹12,349

Returns

₹87,651

(-87.65%)

Returns from Gri Bio Inc. Stock

₹98,160 (-98.16%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Gri Bio Inc. Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Gri Bio Inc.. Average target price of $160

Gri Bio Inc. Share Price Target

Get share price movements and forecasts by analysts on Gri Bio Inc..

What analysts predicted

98.59%UPSIDE

Target Price

$160

Current Price

$2.25

Analyzed by

5 Analysts

Target

$160.00

Gri Bio Inc. target price $160, a slight upside of 98.59% compared to current price of $2.25. According to 5 analysts rating.

Gri Bio Inc. Stock’s Investor Sentiment and Interest

Search interest for Gri Bio Inc. Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 26, 2026 to March 28, 2026

Change:-54% versus previous 30 day period

Gri Bio Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	5	-	-	-	2	-	22	6	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	-2	-1	-2	-2	-1	-3	-2	-3	-2
EBITDA	-2	-1	-1	-2	-2	-1	-3	-2	-3	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	-1	-2	-2	-1	-3	-2	-3	-2
Income Tax Expense	0	1	-	0	-	0	-	-	0	-
Net Income	-2	-2	-1	-2	-2	-1	-3	-2	-3	-2
Net Profit Margin	0.00%	-37.15%	0.00%	0.00%	0.00%	-84.77%	0.00%	-12.83%	-53.04%	0.00%

Gri Bio Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	-	-	21	22	-
Gross Profit	0	0	0	0	0	0
Operating Income	-1	-9	-2	-11	-8	-11
EBITDA	-1	-9	-2	-10	-8	-11
Interest Expense	0	0	0	2	0	-
Depreciation	-	0	0	0	0	0
Income Before Tax	-2	-9	-3	-13	-8	-11
Income Tax Expense	0	0	0	2	-	-
Net Income	-2	-9	-3	-13	-8	-11
Net Profit Margin	-2531.00%	0.00%	0.00%	-59.89%	-36.41%	0.00%

Gri Bio Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-1	-2	-2	-1	-3	-2	-3	-2
Operating Cash Flow	-5	-2	-2	-2	-1	-1	-3	-2	-2
Investing Cash Flow	-	-	-	-	-	-	0	-	0
Financing Cash Flow	3	4	4	0	2	0	5	1	7
Change in Cash	-1	2	2	-1	0	-1	1	-1	4

Gri Bio Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-4	-1	-3	-13	-8	-11
Operating Cash Flow	-2	-3	0	-1	-8	-8	-10
Investing Cash Flow	-	0	-3	0	0	-	0
Financing Cash Flow	6	0	0	1	10	11	13
Change in Cash	3	-3	0	0	1	3	3

Insights on Gri Bio Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 116.3%
NEGATIVE IMPACT
Price Dip
In the last 3 months, GRI stock has moved down by -70.5%

About Gri Bio Inc.

gri is a development stage biotech company fundamentally changing the way inflammatory disease is treated. gri’s natural killer t (nkt) cell-based therapies are being developed for liver disease and acute liver failure. nkt cells share properties of both nk and t cells and are a functional link between the innate and adaptive immune responses. type 1 nkt cells play a critical role in initiating and propagating the inflammatory response and the hepatic injury that is observed in liver disease. gri’s lead program, gri-0621, is an inhibitor of type i nkt cells and is being developed as a novel oral therapeutic for acute liver failure.

Organisation	Gri Bio Inc.
Headquarters	2223 Avenida de la Playa, La Jolla, CA, United States, 92037
Industry	Miscellaneous
CEO	Dr. W. Marc Hertz Ph.D.
E-voting on shares	Click here to vote

Key Management of Gri Bio Inc.

Name	Title
Ms. Leanne M. Kelly	CFO & Corporate Secretary
Dr. Albert Agro Ph.D.	Co-Founder & Chief Medical Officer
Dr. W. Marc Hertz Ph.D.	Co-Founder, CEO, President & Director
Dr. Vipin Kumar Chaturvedi Ph.D.	Co-Founder & Chief Scientific Officer

FAQs

What is Gri Bio Inc. share price today?

Gri Bio Inc. share price today is $2.25 as on March 28, 2026 at 1:28 am IST at the close of the market. Gri Bio Inc. share today touched a day high of $2.37 and a low of $2.22.

What is the 52 week high and 52 week low for Gri Bio Inc. share?

Gri Bio Inc. share touched a 52 week high of $311.36 on April 1, 2025 and a 52 week low of $2.1 on February 12, 2026. Gri Bio Inc. stock price today i.e. March 28, 2026 at 1:28 am IST is closed at $2.25,which is 99.28% down from its 52 week high and 7.14% up from its 52 week low.

What is Gri Bio Inc.'s market capitalisation today?

Gri Bio Inc. market capitalisation is $0.00T as on March 28, 2026 at 1:28 am IST.

How to invest in Gri Bio Inc. Stock (GRI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Gri Bio Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gri Bio Inc. Shares that will get you 0.6667 shares as per Gri Bio Inc. share price of $2.25 per share as on March 28, 2026 at 1:28 am IST.

What is the minimum amount required to buy Gri Bio Inc. Stock (GRI) from India?

Indian investors can start investing in Gri Bio Inc. (GRI) shares with as little as ₹94.651 or $1 (as of March 28, 2026 at 3:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Gri Bio Inc. stock (as per the Rupee-Dollar exchange rate as on March 28, 2026 at 3:41 pm IST). Based on Gri Bio Inc. share’s latest price of $2.25 as on March 28, 2026 at 1:28 am IST, you will get 4.4444 shares of Gri Bio Inc.. Learn more about fractional shares .